Thomas Verwanger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Interests
Thomas Verwanger has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Barbara Krammer
Department of Molecular Biology, University of Salzburg, Hellbrunnerstraße 34, 5020 Salzburg, Austria
22 shared publications - Rehab M. Amin
Department of Laser Applications in Photochemistry, National Institute of Laser Enhanced Sciences, Cairo University, Egypt
4 shared publications Barbara Krammer
Department of Molecular Biology, University of Salzburg, Hellbrunnerstr. 34, 5020 Salzburg, Austria
3 shared publications- Chiara Cabrele
Department of Molecular Biology, University of Salzburg, Billrothstrasse 11, 5020 Salzburg, Austria
3 shared publications Cornelia Roschger
Department of Molecular Biology, University of Salzburg, Billrothstrasse 11, 5020 Salzburg, Austria
3 shared publications- Aleksandra Kawczyk-Krupka
Department of Internal Diseases, Angiology and Physical Medicine, Center for Laser Diagnostics and Therapy, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, 40-055 Katowice, Poland
2 shared publications
Latest Publications
- Open Access
- 15 April 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 13 (16) , 7648-7666
Gold nanoparticles (AuNPs) impair LPS-driven immune responses by promoting a tolerogenic-like dendritic cell phenotype with altered endosomal structures
This study shows that gold nanoparticles promote the differentiation of dendritic cells to a tolerogenic-like phenotype, affecting their ability to induce antibacterial immune responses mediated by Th1 cells and to activate central memory T cells.
- 15 April 2021
- Published by Royal Society of Chemistry (RSC) in Nanoscale
- Vol. 13 (16) , 7648-7666
Open AccessGold nanoparticles (AuNPs) impair LPS-driven immune responses by promoting a tolerogenic-like dendritic cell phenotype with altered endosomal structures
This study shows that gold nanoparticles promote the differentiation of dendritic cells to a tolerogenic-like phenotype, affecting their ability to induce antibacterial immune responses mediated by Th1 cells and to activate central memory T cells.
- 1 June 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 22, 137-139
Influence of ALA-mediated photodynamic therapy on secretion of interleukins 6, 8 and 10 by colon cancer cells in vitro
- 1 June 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 22, 137-139
Influence of ALA-mediated photodynamic therapy on secretion of interleukins 6, 8 and 10 by colon cancer cells in vitro
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 16-18
Secretion of the angiogenic factor VEGF after photodynamic therapy with ALA under hypoxia-like conditions in colon cancer cells
- 1 March 2018
- Published by Elsevier in Photodiagnosis and Photodynamic Therapy
- Vol. 21, 16-18
Secretion of the angiogenic factor VEGF after photodynamic therapy with ALA under hypoxia-like conditions in colon cancer cells
- 1 January 2018
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 178, 521-529
Reduction of cancer cell viability by synergistic combination of photodynamic treatment with the inhibition of the Id protein family
- 1 January 2018
- Published by Elsevier in Journal of Photochemistry and Photobiology B: Biology
- Vol. 178, 521-529
Reduction of cancer cell viability by synergistic combination of photodynamic treatment with the inhibition of the Id protein family
- 1 December 2017
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 98, 415-420
Fluorescence-based CdTe nanosensor for sensitive detection of cytochrome C
- 1 December 2017
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 98, 415-420
Fluorescence-based CdTe nanosensor for sensitive detection of cytochrome C
- 19 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (18) , 1480
Front Cover: Targeting of a Helix‐Loop‐Helix Transcriptional Regulator by a Short Helical Peptide (ChemMedChem 18/2017)
- 19 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (18) , 1480
Front Cover: Targeting of a Helix‐Loop‐Helix Transcriptional Regulator by a Short Helical Peptide (ChemMedChem 18/2017)
- Open Access
- 12 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 11249
Oscillations of ultra-weak photon emission from cancer and non-cancer cells stressed by culture medium change and TNF-α
Cells spontaneously emit photons in the UV to visible/near-infrared range (ultra-weak photon emission, UPE). Perturbations of the cells’ state cause changes in UPE (evoked UPE). The aim of the present study was to analyze the evoked UPE dynamics of cells caused by two types of cell perturbations (stressors): (i) a cell culture medium change, and (ii) application of the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α). Four types of human cell lines were used (squamous cell carcinoma cells, A431; adenocarcinomic alveolar basal epithelial cells, A549; p53-deficient keratinocytes, HaCaT, and cervical cancer cells, HeLa). In addition to the medium change, TNF-α was applied at different concentrations (5, 10, 20, and 40 ng/mL) and UPE measurements were performed after incubation times of 0, 30, 60, 90 min, 2, 5, 12, 24, 48 h. It was observed that (i) the change of cell culture medium (without added TNF-α) induces a cell type-specific transient increase in UPE with the largest UPE increase observed in A549 cells, (ii) the addition of TNF-α induces a cell type-specific and dose-dependent change in UPE, and (iii) stressed cell cultures in general exhibit oscillatory UPE changes.
- 12 September 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 11249
Open AccessOscillations of ultra-weak photon emission from cancer and non-cancer cells stressed by culture medium change and TNF-α
Cells spontaneously emit photons in the UV to visible/near-infrared range (ultra-weak photon emission, UPE). Perturbations of the cells’ state cause changes in UPE (evoked UPE). The aim of the present study was to analyze the evoked UPE dynamics of cells caused by two types of cell perturbations (stressors): (i) a cell culture medium change, and (ii) application of the pro-inflammatory cytokine tumor necrosis factor alpha (TNF-α). Four types of human cell lines were used (squamous cell carcinoma cells, A431; adenocarcinomic alveolar basal epithelial cells, A549; p53-deficient keratinocytes, HaCaT, and cervical cancer cells, HeLa). In addition to the medium change, TNF-α was applied at different concentrations (5, 10, 20, and 40 ng/mL) and UPE measurements were performed after incubation times of 0, 30, 60, 90 min, 2, 5, 12, 24, 48 h. It was observed that (i) the change of cell culture medium (without added TNF-α) induces a cell type-specific transient increase in UPE with the largest UPE increase observed in A549 cells, (ii) the addition of TNF-α induces a cell type-specific and dose-dependent change in UPE, and (iii) stressed cell cultures in general exhibit oscillatory UPE changes.
- 5 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (18) , 1497-1503
Targeting of a Helix‐Loop‐Helix Transcriptional Regulator by a Short Helical Peptide
The Id proteins (Id1–4) are cell‐cycle regulators that play a key role during development, in cancer and vascular disorders. They contain a conserved helix‐loop‐helix (HLH) domain that folds into a parallel four‐helix bundle upon self‐ or hetero‐association with basic‐HLH transcription factors. By using such protein–protein interactions, the Id proteins inhibit cell differentiation and promote cell‐cycle progression. Accordingly, their supporting role in cancer has been convincingly demonstrated, which makes these proteins interesting therapeutic targets. Herein we present a short peptide containing an (i,i+4)‐lactam bridge and a hydrophobic (Φ) three‐residue motif Φ(i)−Φ(i+3)−Φ(i+6), which adopts a helical conformation in water, shows Id protein binding in the low‐micromolar range, penetrates into breast (MCF‐7 and T47D) and bladder (T24) cancer cells, accumulates in the nucleus, and decreases cell viability to ∼50 %. Thus, this cyclopeptide is a promising scaffold for the development of Id protein binders that impair cancer cell viability.
- 5 September 2017
- Published by Wiley in ChemMedChem
- Vol. 12 (18) , 1497-1503
Targeting of a Helix‐Loop‐Helix Transcriptional Regulator by a Short Helical Peptide
The Id proteins (Id1–4) are cell‐cycle regulators that play a key role during development, in cancer and vascular disorders. They contain a conserved helix‐loop‐helix (HLH) domain that folds into a parallel four‐helix bundle upon self‐ or hetero‐association with basic‐HLH transcription factors. By using such protein–protein interactions, the Id proteins inhibit cell differentiation and promote cell‐cycle progression. Accordingly, their supporting role in cancer has been convincingly demonstrated, which makes these proteins interesting therapeutic targets. Herein we present a short peptide containing an (i,i+4)‐lactam bridge and a hydrophobic (Φ) three‐residue motif Φ(i)−Φ(i+3)−Φ(i+6), which adopts a helical conformation in water, shows Id protein binding in the low‐micromolar range, penetrates into breast (MCF‐7 and T47D) and bladder (T24) cancer cells, accumulates in the nucleus, and decreases cell viability to ∼50 %. Thus, this cyclopeptide is a promising scaffold for the development of Id protein binders that impair cancer cell viability.
- Open Access
Boosting Tumor-Specific Immunity Using PDT
Photodynamic therapy (PDT) is a cancer treatment with a long-standing history. It employs the application of nontoxic components, namely a light-sensitive photosensitizer and visible light, to generate reactive oxygen species (ROS). These ROS lead to tumor cell destruction, which is accompanied by the induction of an acute inflammatory response. This inflammatory process sends a danger signal to the innate immune system, which results in activation of specific cell types and release of additional inflammatory mediators. Activation of the innate immune response is necessary for subsequent induction of the adaptive arm of the immune system. This includes the priming of tumor-specific cytotoxic T lymphocytes (CTL) that have the capability to directly recognize and kill cells which display an altered self. The past decades have brought increasing appreciation for the importance of the generation of an adaptive immune response for long-term tumor control and induction of immune memory to combat recurrent disease. This has led to considerable effort to elucidate the immune effects PDT treatment elicits. In this review we deal with the progress which has been made during the past 20 years in uncovering the role of PDT in the induction of the tumor-specific immune response, with special emphasis on adaptive immunity.
Open AccessBoosting Tumor-Specific Immunity Using PDT
Photodynamic therapy (PDT) is a cancer treatment with a long-standing history. It employs the application of nontoxic components, namely a light-sensitive photosensitizer and visible light, to generate reactive oxygen species (ROS). These ROS lead to tumor cell destruction, which is accompanied by the induction of an acute inflammatory response. This inflammatory process sends a danger signal to the innate immune system, which results in activation of specific cell types and release of additional inflammatory mediators. Activation of the innate immune response is necessary for subsequent induction of the adaptive arm of the immune system. This includes the priming of tumor-specific cytotoxic T lymphocytes (CTL) that have the capability to directly recognize and kill cells which display an altered self. The past decades have brought increasing appreciation for the importance of the generation of an adaptive immune response for long-term tumor control and induction of immune memory to combat recurrent disease. This has led to considerable effort to elucidate the immune effects PDT treatment elicits. In this review we deal with the progress which has been made during the past 20 years in uncovering the role of PDT in the induction of the tumor-specific immune response, with special emphasis on adaptive immunity.
- 1 June 2016
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 63, 46-51
A new biocompatible nanocomposite as a promising constituent of sunscreens
- 1 June 2016
- Published by Elsevier in Materials Science and Engineering: C
- Vol. 63, 46-51
A new biocompatible nanocomposite as a promising constituent of sunscreens